SLC16A7 and non-small cell lung carcinoma: Guo’s findings suggested that clinical outcomes might be influenced by SNPs (single nucleotide polymorphisms) in MCT1 and MCT2 genes, which could be used to predict the response to adjuvant chemotherapy in patients with NSCLC receiving surgical treatment in future study [36].